In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.
HealthDay on MSN1d
Clinical Guidelines Updated for Evaluation, Management, Treatment of CKDIn a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Addressing patients with chronic kidney disease requires a commitment to data, education, and community, specifically in those affected by social determinants of health (SDOH).
Study findings support the monitoring and management of iron status in patients with early stages of chronic kidney disease (CKD).
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Q4 2024 Management View CEO John Tucker highlighted FUROSCIX's Q4 2024 net revenue of $12.2 million, which aligns with the previously announced range of $12 million to $12.3 million. For the full year ...
Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
Uganda has made significant strides in kidney care, including the establishment of dialysis centres and successful kidney ...
"Learn about the importance of kidney health and comprehensive screening during National Kidney Month. Discover how CarelonRx ...
Christopher Byers, DVM, delivered a session on CKD in cats at the 2025 Fetch Charlotte conference in North Carolina ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback